VA Office of Research and Development
1,788
269
350
1,189
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
6.7%
120 terminated/withdrawn out of 1788 trials
90.8%
+4.3% vs industry average
8%
136 trials in Phase 3/4
90%
1072 of 1189 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (1788)
Improving Mental Healthcare Outcomes for Minoritized Veterans Through a Peer-led, Patient Navigation Program (PARTNER-MH 2.0)
Role: lead
Pragmatic Obstructive Sleep Apnea Weight Loss Trial Assessing Effectiveness and Reach
Role: lead
A Computer-Assisted CBT Tool to Enhance Fidelity in CBOCs
Role: lead
Development of a Mobile Health Intervention to Support Functioning of Veterans With Substance Use Disorders
Role: lead
LOw DosE Spironolactone, chlorThAlidone oR Combination in CKD Trial
Role: lead
Aging Well Through Interactions and Scientific Education - Action Plan (AgeWISE-AP)
Role: lead
Detection and Amelioration of Gamma Oscillation Abnormalities in Blast-Related Brain Injury
Role: lead
Blood Flow Monitoring to Prevent Post-Polypectomy Induced Ulcer Bleeding
Role: lead
Using the Multiphase Optimization Strategy to Adapt Cognitive Processing Therapy
Role: lead
Pilot Study of TENS for Ocular Pain
Role: lead
Aerobic Exercise and Cerebrovascular Function
Role: lead
Health Coaching: A Pilot Trial Among Reintegrating Veterans
Role: lead
Coach to Fit Weight Loss Intervention for Individuals With Serious Mental Illness
Role: lead
Integrated CBT to Improve Functioning in Veterans With Anxiety and Substance Use
Role: lead
ERP to Improve Functioning in Veterans With OCD
Role: lead
Imaging SV2A in Mood Disorders
Role: collaborator
A Transdiagnostic Sleep Health Intervention for Veterans With PTSD
Role: lead
Orthotic Treatment of Diabetic Foot Ulcers
Role: lead
Pilot Study of Hospital GamePlan4Care
Role: lead
Manage Emotions to Reduce Aggression (MERA)
Role: lead